Literature DB >> 32001558

Draft Genome Sequences of Eight Strains of Campylobacter helveticus Isolated from Cats and a Dog in New Zealand.

Krunoslav Bojanić1, Anne C Midwinter1, Els Acke1, Jonathan C Marshall1,2, Angela J Cornelius3, Patrick J Biggs4,2,5.   

Abstract

The draft genome sequences for eight isolates of Campylobacter helveticus isolated from companion animals are described and compared with that of the type strain. On average, the genomes are 1,825,025 bp long and have a GC content of 34.4% and 1,885 coding DNA sequences (CDSs). CRISPRs were detected in only one isolate and phages in none.
Copyright © 2020 Bojanić et al.

Entities:  

Year:  2020        PMID: 32001558      PMCID: PMC6992862          DOI: 10.1128/MRA.01244-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Campylobacter helveticus has been isolated from healthy and diarrheic companion animals and is closely related to C. upsaliensis (1). However, C. helveticus has not been isolated from humans with gastroenteritis (2). In a study exploring Campylobacter spp. in companion animals and their food (3) (approved by the Massey University Animal Ethics Committee; application number 09/70), C. helveticus isolates from clinically normal cats (seven isolates, one from each) and a dog (one isolate) were sequenced and analyzed with the genome of C. helveticus strain ATCC 51209T (4). Bacteria were isolated and identified as described (3) with subculture onto Columbia horse blood agar (Fort Richard Laboratories, New Zealand) in an H2-enriched microaerobic atmosphere at 37°C. Genomic DNA was extracted from the Columbia horse blood agar subcultures using a QIAamp DNA minikit (Qiagen, Germany) and sequenced at New Zealand Genomics Ltd. (Massey University, New Zealand) using a MiSeq instrument (Illumina, Australia) following the manufacturer’s instructions, with paired read lengths of 250 base pairs after library preparation using the Nextera XT library kit (Illumina). Default parameters and settings were used for all software unless otherwise described. Velvet version 1.2.10 (5) was used for de novo genome assembly. Sequence data were quality processed, analyzed, and assembled using ea-utils (https://bio.tools/ea-utils) within QCtool (https://bio.tools/qctool) and SPAdes version 3.13.0 (6). Assembly statistics for the eight New Zealand isolates were extracted from the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) and are described in Table 1. Geneious version 10.2.6 (7) was used to calculate GC values and to check for the presence of the cdtABC operon. Signal peptides from amino acid predictions were discovered using the SignalP-5.0 server (http://www.cbs.dtu.dk/services/SignalP-5.0/).
TABLE 1

Assembly information for eight Campylobacter helveticus isolates from New Zealand

ParameterData for strain:
ACP102bACP108aACP110bACP114bACP123bACP141aACP175aACP183a
No. of reads2,619,9322,218,2601,991,0841,821,7601,155,1921,211,8961,386,3722,157,198
No. of contigs149185180175181155149161
Genome length (bp)1,768,0111,881,7421,859,8621,784,8841,899,3211,821,1441,829,3031,755,938
N50 (bp)29,02730,10226,65133,94328,60230,92032,67330,818
Coverage (×)360309277247159168192296
GC content (%)34.4634.2734.3134.3434.2234.434.3934.53
No. of proteins1,7911,9501,9411,8301,9861,8821,8881,814
No. of rRNAs356541196
No. of tRNAs3934343936353339
No. of other RNAs33333333
No. of genes1,8972,0582,0431,9352,0972,0002,0061,923
No. of signal peptides126146148135152139137137
GenBank accession no.VDBW00000000VDBV00000000VDBU00000000VDBT00000000VDBS00000000VDBR00000000VDBQ00000000VDBP00000000
SRA run no.SRR10248249SRR10248248SRR10248247SRR10248246SRR10248244SRR10248243SRR10248242SRR10248245
BioSample no.SAMN11567273SAMN11567274SAMN11567275SAMN11567276SAMN11567277SAMN11567278SAMN11567279SAMN11567280
SRA no.SRX6966295SRX6966296SRX6966297SRX6966298SRX6966299SRX6966300SRX6966301SRX6966302
HostFelis catusFelis catusFelis catusFelis catusFelis catusCanis lupus familiarusFelis catusFelis catus
Assembly information for eight Campylobacter helveticus isolates from New Zealand For functional and core genome analysis, concatenated contigs were annotated with Prokka version 1.11 (8) using the default settings and the predicted amino acid sequences were searched against the Clusters of Orthologous Groups (COGs) database (using COGsoft version 201204) (9). COGs were considered to be core if present in all of the isolates. CRISPRFinder (10) and PHAST (11) were used to identify clustered regularly interspaced short palindromic repeats (CRISPRs) and phage, respectively. Abricate version 0.8.11 (https://github.com/tseemann/abricate) was used via Nullarbor to screen for genes related to antimicrobial resistance. Aligning the coding DNA sequences (CDSs) to the COGs database gave 1,243 unique COGs in the pangenome of the eight isolates plus the reference genome, with an average 1,169 COGs and 1.34 copies per genome. The C. helveticus core genome contained 1,083 COGs, approximately 87.1% of the pangenome. CRISPRs were detected in one isolate (ACP114b), although the other isolates had 1 to 3 “questionable” CRISPRs detected. No intact bacteriophage insertions were identified. Only two genes associated with antimicrobial resistance were found, both in ACP110b. The cdtABC operon (cytolethal distending toxin) was detected in all eight isolates.

Data availability.

The C. helveticus draft genome sequences have been deposited in GenBank under the BioProject accession number PRJNA541328, with the individual accession numbers shown in Table 1.
  10 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

Review 3.  A genomic perspective on protein families.

Authors:  R L Tatusov; E V Koonin; D J Lipman
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

4.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

5.  Isolation of Campylobacter spp. from Client-Owned Dogs and Cats, and Retail Raw Meat Pet Food in the Manawatu, New Zealand.

Authors:  K Bojanić; A C Midwinter; J C Marshall; L E Rogers; P J Biggs; E Acke
Journal:  Zoonoses Public Health       Date:  2016-11-12       Impact factor: 2.702

6.  Campylobacter helveticus sp. nov., a new thermophilic species from domestic animals: characterization, and cloning of a species-specific DNA probe.

Authors:  J Stanley; A P Burnens; D Linton; S L On; M Costas; R J Owen
Journal:  J Gen Microbiol       Date:  1992-11

7.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

8.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

9.  Complete Genome Sequence of the Campylobacter helveticus Type Strain ATCC 51209.

Authors:  William G Miller; Emma Yee; James L Bono
Journal:  Genome Announc       Date:  2017-05-25

10.  CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats.

Authors:  Ibtissem Grissa; Gilles Vergnaud; Christine Pourcel
Journal:  Nucleic Acids Res       Date:  2007-05-30       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.